![](https://tracker.live.rns-distribution.com/track.live-rns/4204015_75d1671758db0ed18eba2dbba83793b2.png)
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, WITHIN, INTO OR IN THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, THE REPUBLIC OF IRELAND OR JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL.
Fragrant Prosperity Holdings Limited
("FPP" or the "Company")
Update regarding the CiiTECH transaction and LR5 notification.
7 December 2021
On 24 May 2021 Fragrant Prosperity Holdings Limited (LSE: FPP) announced the potential acquisition of CiiTECH Limited (the "Acquisition") and the entry into a letter of Intent (the "LOI"). Although the exclusivity period in the LOI has expired, the Company has continued to progress the transaction with CiiTECH and it is now reaching its closing stages. As updated earlier today, the Company has submitted a complete draft of the prospectus to the FCA containing details of the proposed acquisition of CiiTECH and is in the advanced stages of seeking FCA approval for that prospectus.
As under the Listing Rules, the Acquisition is classified as a reverse takeover, it resulted in the suspension of the Company's shares from listing and trading pending publication of a prospectus and accordingly the Company's ordinary shares will remain suspended until such time as the prospectus is published.
Following approval and publication of the prospectus, the Company's existing listing will be cancelled and an application for the enlarged share capital to be admitted to the Official List and to trading on the main market for listed securities of the London Stock Exchange will be made.
- Ends -
Enquiries
Fragrant Prosperity Holdings Limited Simon Retter
| +44 (0)20 3137 1902
|
Optiva Securities - Broker to FPP Vishal Balasingham
| +44 (0)20 3137 1903
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.